Paid Clinical Trials in New Orleans, LA
As of July 2026, 406 paid clinical trials are recruiting in New Orleans, Louisiana. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
New Orleans offers studies at sites including University Medical Center New Orleans for conditions such as Atrial Fibrillation, Hypertension, Malignant Solid Neoplasm, Breast Cancer. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in New Orleans
Trials by drug in New Orleans
Filter results
Newly added in New Orleans
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
367 clinical trials
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention
An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD (EMPOWER-1)
Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
A Study to Assess the Effectiveness and Safety of IPN10200 Over Time in Adults With Moderate to Severe Wrinkle-like Lines Between the Eyebrows
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain
A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa
Study of DONQ52 in Active Celiac Disease
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
A Study of Dotinurad Versus Allopurinol in Participants With Gout
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
Top Research Study Locations in New Orleans
Researchers run research studies in New Orleans, LA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| University Medical Center New Orleans | Anatomic Stage II Breast Cancer AJCC v8, Heart Failure, Malignant Solid Neoplasm | 51 |
| Ochsner Medical Center Jefferson | Advanced Malignant Solid Neoplasm, B Acute Lymphoblastic Leukemia, Malignant Solid Neoplasm | 47 |
| Ochsner Clinic Foundation | Neoplasm Metastasis, Acute Stroke, Chronic Low-back Pain | 34 |
| Children's Hospital New Orleans | Malignant Solid Neoplasm, B Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | 31 |
| Louisiana State University Health Science Center | Anatomic Stage IV Breast Cancer AJCC v8, Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum | 19 |
| Tulane University | Ulcerative Colitis, Aneurysm, Brain, Anxiety | 15 |
| DelRicht Research | Chronic Pain, Osteoarthritis, Knee, Acute Gout Flare | 13 |
| Tulane University School of Medicine | Von Willebrand Disease (VWD), Von Willebrand Disease (VWD), Type 1, Von Willebrand Disease (VWD), Type 2 | 12 |
| Ochsner Medical Center | Aortic Valve Disease, Aortic Valve Stenosis, Hypertension | 11 |
| University Medical Center | Atrial Fibrillation, Hidradenitis Suppurativa, Abdominal Wound Dehiscence | 10 |
| Ochsner Baptist Medical Center | Abdominal Wound Dehiscence, Anal Fistula, Bronchopulmonary Dysplasia | 9 |
| Touro Infirmary | Anatomic Stage II Breast Cancer AJCC v8, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | 9 |
| Louisiana State University | Aortic Stenosis, Calcific, Aortic Valve Stenosis, Articular Fractures | 7 |
| Louisiana State University Health Sciences Center | Aortoiliac Occlusive Disease, Breast Cancer, Dacryocystitis | 7 |
| Ochsner Health | Pregnancy, Advanced Solid Tumor, Age-related Macular Degeneration (AMD) | 7 |
| East Jefferson General Hospital | Atrial Fibrillation, Atrial Arrhythmia, Atrial Flutter | 6 |
| Tulane University Medical Center | Acute Kidney Injury, Covid19, Droopy Eyelid | 5 |
| The Policy & Research Group | Teen Pregnancy Prevention | 4 |
| Ochsner Health System | Cardiovascular Diseases, Eustachian Tube Dysfunction, Functional Mitral Regurgitation | 3 |
| Southeast Louisiana Veterans Health Care System, New Orleans, LA | Secure Firearm Storage, Suicidal Ideation, Suicide | 3 |
| Tulane Cancer Center | Bladder Carcinoma, Cutaneous Melanoma, Endometrial Carcinoma | 3 |
| Tulane Doctors - Speciality Care - Napoleon | Atrial Fibrillation, Cardiomyopathies, Obstructive Sleep Apnea | 3 |
| Tulane Medical Center | Community-acquired Pneumonia, Influenza, COVID-19, Interstitial Lung Disease, Kidney Transplant Rejection | 3 |
| University Medical Center - New Orleans | Advanced or Metastatic Castration-Resistant Prostate Cancer (mCRPC), Advanced or Metastatic ER+ HER2- Breast Cancer (mBC), Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) | 3 |
| Clinical Trial Site | Advanced Breast Cancer, Breast Cancer, ER Positive Breast Cancer | 2 |
Active & Upcoming Studies in New Orleans (2026)
Recruiting trials in New Orleans grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (115 active studies)
- Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer · Phase 2 · National Cancer Institute (NCI)
- A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer · Phase 3 · J-Pharma Co., Ltd.
Cardiovascular (38 active studies)
- The RESPLASH Study · Tulane University
- LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2 · Phase 3 · Tenax Therapeutics, Inc.
Neurology & pain (35 active studies)
- A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Chronic Low Back Pain · Phase 2 · Eli Lilly and Company
- A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain · Phase 2 · Eli Lilly and Company
HIV / STI (12 active studies)
- Combatting HIV Or Other STIs Early (CHOOSE) · Phase 2 · Westat
- Are Louisiana Pharmacists PrEPared? Implementing Training and an Active PrEP (Pre-Exposure Prophylaxis) Prescribing Surveillance Program · Xavier University of Louisiana.
Diabetes & metabolic (12 active studies)
- Periodontal Inflammation and Epigenetics in Obese Individuals · Louisiana State University Health Sciences Center in New Orleans
- A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes · Phase 3 · Hoffmann-La Roche
Mental health & behavior (7 active studies)
- A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD) · Phase 2 · Tonix Pharmaceuticals, Inc.
- Improving Health Literacy in Patients With Schizophrenia Spectrum Disorder · Louisiana State University Health Sciences Center in New Orleans
Vaccines (5 active studies)
- A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose · Phase 3 · Pfizer
- Intervention to Prevent Behavioral Health Symptoms Among Pandemic Affected Children · University of Illinois at Urbana-Champaign
Pediatric (5 active studies)
- A Study to Evaluate the Effect of Aficamten in Pediatric Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM). · Phase 2, Phase 3 · Cytokinetics
- Multicenter HomeVENT: Home Values and Experiences Navigation Track · Johns Hopkins University
Eye & vision (3 active studies)
- The Effect of Lumify™ on Ocular Redness, Intraocular Pressure, and Eyelid Position in Glaucoma Patients · Phase 4 · Tulane University
- A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma · Phase 3 · AbbVie
Common conditions studied in New Orleans
- Atrial Fibrillation (7 active studies)
- Hypertension (7 active studies)
- Malignant Solid Neoplasm (7 active studies)
- Breast Cancer (6 active studies)
- Heart Failure (6 active studies)
- Cancer (5 active studies)
Leading research sponsors in New Orleans
- National Cancer Institute (NCI)
- Tulane University
- Children's Oncology Group
- Eli Lilly and Company
- NRG Oncology
Frequently asked questions
How many paid clinical trials are currently recruiting in New Orleans?
There are approximately 406 recruiting clinical trials in New Orleans, Louisiana listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in New Orleans pay participants?
Most recruiting trials in New Orleans compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in New Orleans?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in New Orleans?
The most common conditions under active study in New Orleans include Atrial Fibrillation (7), Hypertension (7), Malignant Solid Neoplasm (7), Breast Cancer (6), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in New Orleans?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in New Orleans on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in New Orleans?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in New Orleans?
Recruiting research sites in New Orleans include University Medical Center New Orleans, Ochsner Medical Center Jefferson, Ochsner Clinic Foundation, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in New Orleans right now?
The largest active categories in New Orleans are Cancer & tumors (115), Cardiovascular (38), Neurology & pain (35). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.